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Background: As the population of older adults is growing, the interest in a simple way
to detect characterize amnestic mild cognitive impairment (aMCI), a prodromal stage
of Alzheimer’s disease (AD), is becoming increasingly important. Serious game (SG) -
based cognitive and motor performance profiles while performing everyday activities
and dual-task walking (DTW) “motor signatures” are two very promising markers that
can be detected in predementia states. We aim to compare the consistency, or
conformity, of measurements made by a custom SG with DTW (NAV), a SG without DTW
(DOT), neuropsychological measures and genotyping as markers for early detection
of aMCI.
Methods: The study population included three groups: early AD (n = 86), aMCI (n = 65),
and healthy control subjects (n = 76), who completed the custom SG tasks in three
separate sessions over a 3-month period. Outcome measures were neuropsychological
data across-domain and within-domain intra-individual variability (IIV) and DOT
and NAV latency-based and accuracy-based IIV. IIV reflects a transient, within-
person change in behavioral performance, either during different cognitive domains
(across-domain) or within the same domain (within-domain). Test–retest reliability of
the DOT and NAV markers were assessed using an intraclass correlation (ICC)
analysis.
Results: Results indicated that performance data, such as the NAV latency-based
and accuracy-based IIV, during the task displayed greater reliability across sessions
compared to DOT. During the NAV task-engagement, the executive function, planning,
and motor performance profiles exhibited moderate to good reliability (ICC = 0.6–0.8),
while during DOT, executive function and spatial memory accuracy profiles exhibited
fair to moderate reliability (ICC = 0.3–0.6). Additionally, reliability across tasks was more
stable when three sessions were used in the ICC calculation relative to two sessions.
Discussion: Our findings suggest that “motor signature” data during the NAV tasks were
a more reliable marker for early diagnosis of aMCI than DOT. This result accentuates
the importance of utilizing motor performance data as a metric for aMCI populations
where memory decline is often the behavioral outcome of interest. In conclusion, custom
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SG with DTW performance data provide an ecological and reliable approach for
cognitive assessment across multiple sessions and thus can be used as a use-
ful tool for tracking longitudinal change in observational and interventional studies
on aMCI.
Keywords: mild cognitive impairment, early diagnosis, motor performance, virtual reality, test–retest reliability,
Alzheimer’s disease
Introduction
Even though a number of risk factors for sporadic Alzheimer’s
disease (AD), the most common type of dementia, have been
discussed (e.g., diagnosis of mild cognitive impairment (MCI),
hippocampal atrophy, family history of AD, apolipoprotein-E ε4
allele [APOE-ε4]), one of the most well-documented risk factors
for the disease is increasing age (Ferreira et al., 2014; Naj et al.,
2014). Neurodegenerative changes such as atrophy, which is char-
acteristic of AD, and occasionally of other dementing diseases
such as fronto-temporal lobar dementia (FTLD) or Hippocampal
Sclerosis, have a relatively long pre-morbid asymptomatic period
(Lindberg et al., 2012a; Pelletier et al., 2013). At the same time,
despite the fact that no cognitive symptoms may be obvious dur-
ing the pre-morbid period, by the time AD is diagnosed, suﬃcient
neuronal injury has occurred such that reversal of the disease is
perhaps unlikely (Petersen, 2003; Lindberg et al., 2012b; Lockhart
et al., 2012). This has therefore raised considerable interest in
the prodromal stage of AD, involving revised criteria for diag-
nosing an early clinical stage of AD (“MCI due to AD,” aMCI or
MCI-AD; Dubois and Albert, 2004; Michon, 2009; Sperling et al.,
2011) and “Prodromal AD”(Albert et al., 2011) and incorporating
biomarkers to increase the certainty of the diagnosis (Dickerson
et al., 2013).
The accuracy of early diagnosis for dementia is increas-
ingly important for both therapeutic and scientiﬁc investigations.
Many of the early-onset dementias are treatable, and the presen-
tation of the common degenerative diseases of late life, such as
AD, can be diﬀerent when presenting in the ﬁfth or sixth decade.
The currently available diagnostic tests have moved the ﬁeld
closer to early diagnosis of AD; however, diﬀerential diagnosis is
broad, and a deﬁnitive diagnosis is made only with the develop-
ment of clinical dementia and the presence of amyloid plaques
and neuroﬁbrillary tangles at autopsy (Snowden et al., 2011).
An ideal AD biomarker should be able to satisfy the following
criteria: the ability to diagnose ADwith high sensitivity and speci-
ﬁcity as conﬁrmed by the gold standard of autopsy validation,
detect early-stage disease, and track the progression of AD and
monitor disease progression or therapeutic eﬃcacy (McKhann
et al., 2011). This understanding could oﬀer the potential for
tailored treatments and a speciﬁc diagnosis for both early-onset
and late-onset dementia. MCI-AD, or aMCI, is a term used to
describe early AD signs that precede functional and cognitive
impairment (Sperling et al., 2011) and may be clinically indis-
tinguishable from what is described as “probable AD” (Albert
et al., 2011; Dickerson et al., 2013). Epidemiological studies have
suggested that the most common form of aMCI is a multi-
ple deﬁcit syndrome with memory impairment and a 10–15%
annual risk of conversion to AD (Portet et al., 2006). According
to some recent studies, MCI individuals with amnestic syndrome
of the hippocampal type (HaMCI), compared to those with the
amnestic syndrome of the non-hippocampal type (NHaMCI), are
the leading at-risk subgroup of the MCI population for the devel-
opment of dementia due to AD (Sarazin et al., 2007). However,
it is still controversial whether the tests designed to detect hip-
pocampal amnestic syndrome (Duara et al., 2013), such as atro-
phy of the hippocampus in the CA1 subﬁeld region (Burger, 2010;
Fletcher et al., 2014), are superior to other tests for the detec-
tion of early-stage dementia (Albert et al., 2011; McKhann et al.,
2011). Yet, in addition to the atrophy of hippocampus only in the
CA1 subﬁeld region experts recently developed the harmonized
protocol for the manual segmentation of the whole hippocampus
(Prestia et al., 2013, Alzheimers Dementia). Indeed, after a har-
monization eﬀort lasted 4 years and funded by the Alzheimer’s
Association, world experts converged onto the harmonized seg-
mentation protocol, which. the European Medicines Agency has
qualiﬁed as an enrichment biomarker to enroll mild and mod-
erate as well as predemented AD subjects in regulatory clinical
trials.
Besides the usefulness of cued recall as a diagnostic tool for
aMCI and AD (De Jager et al., 2010; Kelemen and Fenton, 2010;
Carlesimo et al., 2011; Chechko et al., 2014), emerging evidence
has demonstrated the value of walking stability and variability
analysis as an early indicator of aMCI and AD (Persad et al.,
2008; Gillain et al., 2009; Theill et al., 2011;Montero-Odasso et al.,
2012; Muir et al., 2012). More speciﬁcally, prospective studies
over periods of ﬁve and 6 years in cohorts of 427 and 603 older
subjects over 70 years of age demonstrated that initial quantita-
tive measures of gait, such as velocity, variability, and frequency
can predict the risk of developing dementia (Waite et al., 2005;
Verghese et al., 2007; Montero-Odasso et al., 2014). However, the
relationship between cognitive function in everyday abilities and
gait variables in conditions other than normal walking (NW) is
insuﬃciently understood in people with aMCI. In everyday activ-
ities, there are numerous dual-task walking (DTW) situations
that require active involvement of the visual system (Al-Yahya
et al., 2011). Observing how people walk while they perform a
secondary task with a high demand on attention, i.e., a dual-task
paradigm, has been used to assess interactions between cogni-
tion and gait. Executive function is often implicated in DTW
because subjects must walk and adapt to new and/or complex
situations that involve working memory, mental inhibition, and
mental ﬂexibility. In addition, less eﬃcient executive functions in
older adults have shown signiﬁcant contribution to impairments
in spatial memory, especially when spatial interference is high
(Holden and Gilbert, 2012).
Another concept that has recently attracted the attention of
researchers and clinicians is that of cognitive frailty. Recent
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work has deﬁned cognitive frailty as a multi-dimensional geri-
atric syndrome characterized by the simultaneous presence of
both physical frailty and cognitive impairment without the pres-
ence of a concomitant neurological disease (see Kelaiditi et al.,
2013 for a review). Cognitive frailty is viewed as a potential
precursor of neurodegenerative processes (Duron et al., 2014).
However, few studies have made the link between motor fragility
reﬂected by a reduction in walking velocity and cognitive fragility
reﬂected by an early alteration in executive function and have
hypothesized that alteration in motor performance could occur
before detection of cognitive impairment (Perrochon et al.,
2013).
In a similar vein, recent studies have shown that increased
cognitive intra-individual variability (IIV) across accuracy scores
from neuropsychological tests, representing diﬀerent cognitive
domains (across-domain IIV), might serve as a biomarker of
cognitive frailty occurring before detection of prodromal AD
(Kälin et al., 2014). More particularly, latency- (variability across
response time performance scores) and accuracy-based IIV (vari-
ability across accuracy scores – correct vs. wrong responses)
have reportedly been associated with functional decline (Dixon
et al., 2007; Morgan et al., 2012), incident dementia (Holtzer
et al., 2008), and probable AD (Brewster et al., 2012). A more
recent study compared within- and across-domain IIV and
APOE genotype between healthy control subjects (HCS), MCI,
and AD in a single comparative study and found that within-
domain IIV may constitute a cognitive marker for the detection
of prodromal AD at the MCI stage, whereas across-domain
IIV may detect beginning AD at the MCI stage (Kälin et al.,
2014).
In this context, computerized cognitive assessments, such
as serious games (SGs), can ideally be applied to detect sub-
tle changes in both DTW and IIV between HCS and aMCI
performance proﬁles (Robert et al., 2014). There is already
evidence that SG can be successfully employed for the char-
acterization of episodic and prospective memory proﬁles in
MCI and AD (Werner et al., 2009; Weniger et al., 2011;
Plancher et al., 2012) or even early screening for aMCI (Tarnanas
et al., 2013, 2014). According to the literature, SG interac-
tions require coordination of information by eliciting medium
to high cognitive control, such as inhibition of external stim-
uli or processing speed (e.g., reaction time at interactive events),
which is believed to be aﬀected by aging (De Lillo and James,
2012; Korsch et al., 2014). Very recently, an innovative DTW
concept for detecting cognitive impairment eliciting medium
to high cognitive control, called the Walking Stroop Carpet,
was demonstrated by Perrochon et al. (2013), but to our
knowledge, this is the ﬁrst study reporting on a complex everyday
activities SG employing DTW, which might indicate prodro-
mal AD.
The aim of this study was to (1) systematically evaluate the
reliability of two SGs—a high cognitive control, requiring inhi-
bition of external stimuli, and planning a virtual day-out task
without DTW (DOT) and a high cognitive control, requiring
inhibition, navigation task with DTW (NAV)—and (2) explore
the stability of test–retest measurements as a factor of the number
of SG sessions.
Materials and Methods
Participants
A total of 270 participants (HCS n = 100, aMCI n = 80, and
AD n = 90) were considered for analysis from ongoing stud-
ies at the 3rd Neurological Clinic of the Aristotle University
of Thessaloniki, Greece and from the Greek Association for
Alzheimer Disease and Related Disorders (GAADRDs) Memory
Clinics, belonging to the 3rd Neurological Clinic of the Aristotle
University of Thessaloniki. The study was carried out in accor-
dance with the Declaration of Helsinki, and the participants
were recruited from the outpatient population of the GAADRD
Memory Clinics or by advertisement in the local media. All
subjects had complete cognitive baseline data acquired between
January 2010 and April 2013 with written informed consent
obtained prior to study participation. From the original HCS
sample, 24 subjects were excluded from the analyses due to alco-
hol abuse (n = 2), dropout (n = 6), and medication (n = 16).
Also, 15 aMCI and six early AD subjects were also excluded
due to dropout after the initial assessment. Thus, a total of 76
HCS, 65 aMCI, and 86 early AD patients were eligible for the
analyses.
Amnestic MCI was diagnosed according to the criteria of
Winblad et al. (2004), and all diagnoses were made by a mul-
tidisciplinary team under the supervision of an experienced
psychiatrist. The diagnosis was made if the patient met the fol-
lowing criteria: (1) memory complaint, (2) abnormal memory
for age, (3) normal activities of daily living, (4) normal general
cognitive function, and (5) not demented. Structural magnetic
resonance imaging (MRI) data were also available in our aMCI
cases in order to exclude other conspicuous brain abnormali-
ties that could account for cognitive decline. The diagnosis of
AD was done according to the International Working Group
(IWG-2) criteria considering three main markers: abnormal neu-
ropsychological assessment, medial temporal atrophy on MRI,
and abnormal Abeta42 or tau protein concentrations in the CSF
(Dubois et al., 2014). Additionally, all three groups (HC, aMCI,
and early AD) were screened for disorders, which could poten-
tially produce cognitive impairment, i.e., depression; psychiatric,
neurological, and other diseases. Such subjects were excluded if
there were such disorders or medication use potentially aﬀecting
cognition. Furthermore, it was ascertained that all participants
had normal or corrected to normal vision. All participants but
three older adults were right-handed, according to the Edinburgh
Handedness Inventory (Oldﬁeld, 1971).
Neuropsychological and Psychomotor
Examination
All subjects were assessed with a standardized neuropsy-
chological test battery. The neuropsychological test battery
consisted of multiple tests covering the following cognitive
domains: working and episodic memory, executive function,
attention/psychomotor processing speed, language, and visual-
constructive abilities. The Mini–Mental State Examination
(Folstein, 1975) was used to assess global cognitive function-
ing. For episodic memory, the Grober–Buschke scale was used
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(Grober et al., 1988; Carlesimo et al., 2011). Short-term memory
and working memory were investigated using a digit span for-
ward test (Ramsay and Reynolds, 1995). Tests of executive func-
tioning included verbal ﬂuency and category ﬂuency (the Set Test;
Isaacs and Akhtar, 1972), Stroop (Stirling, 1979), and the TMT B
(Tombaugh, 2004). Long termmemory was assessed with the Rey
Auditory Verbal Learning Test (RAVLT; Rosenberg et al., 1984).
We determined impairment if at least one score per domain was
1.5 SD below group means compared to test-speciﬁc normative
data.
In addition to the neuropsychological examination, partici-
pants also completed a baseline psychomotor evaluation in order
to exclude physical frailty or other forms of physical disability that
might aﬀect the reliability of both DTW and across-domain and
within-domain latency- and accuracy-based IIV across SG per-
formance proﬁles, such as arthritis. The psychomotor examina-
tion included a number of simple and complex measures address-
ing the ability to understand and perform with accuracy speciﬁc
physical performance tasks. These tasks included the following:
(a) “Gait-speed” was measured as the time (to 0.1 s) required
for a participant to walk a 4.6-m course at his or her usual pace
after starting from a standstill and recorded by stopwatch, and
b) the “Finger-Tapping Test” measured both the dominant and
non-dominant hand using a computerized screening test, which
measured ﬁnger tapping speed for a given duration of 10 s.
Quantitative Gait Assessment
We performed a baseline motor evaluation of single-task spon-
taneous walking for 10 m in a normal environment on an 8-m
electronic walkway (GAITRite R©, CIR Systems Inc, Sparta, NJ,
USA). This tool is equipped with a portable, pressure-sensitive
electronic walkway [793 cm × 61 cm × 0.6 cm (L × W × H)]
which provides data for both spatial and temporal gait param-
eters. The simple-task trial consisted of walking the length of
the mat at the participant’s usual pace. For the dual-task trials,
participants walked at their usual pace, with no instruction to
prioritize the gait or cognitive task, while doing the following
cognitive tasks aloud: (i) counting backward from 100 by ones
and (ii) naming animals. To balance and minimize the eﬀects of
learning and fatigue, the order of the dual tasks was randomized.
Allowing both gait and cognitive tasks to vary provides a bet-
ter representation of daily living activities, and the reliability of
this protocol in people with MCI has been previously established
(Montero-Odasso et al., 2009).
SG Hardware Setup
The SG used is patent pending (XtremeVRI AG, Winterthur,
Switzerland) and used mobile phone based Augmented Reality
(AR) in order to present cognitive tasks and record all behav-
ioral and kinetic responses while the subject navigated the AR
environment inside his house (Figure 1).
DOT and NAV Tasks
The novel SG used in this study consisted of two modules simu-
lating complex activities of daily living (CADL): the 3D immer-
sive reality day-out complex task without DTW (DOT) and the
3D immersive reality spatial NAV. The DOT was a complex task
breakdown followed by a rehearsal exercise of a virtual apartment
building ﬁre evacuation drill. The drill included six diﬀerent sce-
narios of increasing diﬃculty, where participants navigated the
virtual environment using a ﬁrst-person perspective and simple
hand pointing gestures for forward, backward, and left, and right
lateral movement, respectively. They could also use natural ﬁnger
pointing and grabbing gestures in order to select, pick, drop, and
move objects inside the virtual environment and had to complete
each within 8 min. All participant movement within the virtual
building was recorded at 10 Hz and represented as a series of x, y,
z coordinates, with actions annotated and time stamped.
The DOT naturalistic actions script was based on an ordered
list of right and wrong actions that was prepared by an occupa-
tional psychologist and was used to examine executive function
and prospective memory as well as planning and reasoning in
a complex emergency routine. The ﬁre evacuation drill setting
had six diﬀerent simulated ﬁre situations (from easy to more
diﬃcult) taking place at a virtual apartment block with three
levels and ﬁve apartments per level. The task put a medium to
high load on the cognitive control processes with which older
adults prioritize, organize, initiate, and complete a number of
FIGURE 1 | The custom SG with DTW setup.
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subroutines (e.g., pick-up the phone and call the ﬁre depart-
ment, sound the ﬁre-alarm) in order to evacuate safely and in the
fastest possible way from an apartment level (e.g., second ﬂoor)
to the ground area (e.g., determine and gather information on
the size of the ﬁre, avoid smoke, avoid wrong actions like using
the elevator). In this sense, DOT is a complex activity of daily
living, which previous research showed is a valid and reliable
indicator of cognitive decline in elderly persons (Tarnanas et al.,
2013).
The NAV task took place at the same virtual apartment block
but with the player challenged in diﬀerent aspects of executive
function, such as volition, self-awareness, planning, inhibition
of dominant response, and external distraction during response
control, and dual-task coordination. The goal at diﬃculty level
1 was to navigate from point A to point B, after the route was
demonstrated by a ﬁrst-person perspective camera walkthrough
without iteration. The NAV task took place with six levels of dif-
ﬁculty, with the addition of one more point of destination per
diﬃculty level—for example, level 3 has three points to reach,
level 4 has four, etc. Each level had a starting position (start) and
an end position (goal) and multiple ways to arrive from start to
goal. Participants were asked to make their way from start to goal
in the shortest time possible. The NAV task placed a medium to
high demand on higher order cognitive control processes, such
as following a mental strategy to reach the goal with performance
monitoring while inhibiting environmental stressors, such as vir-
tual characters forcing the player to choose a less familiar route
or interact with distractors in the virtual environment, a process
which typically involves cognitive control.
According to the literature, interactions such as the DOT and
NAV tasks, require participants to follow a mental strategy and
monitor their performance by eliciting medium to high cognitive
control, such as inhibition of external stimuli or processing speed
(e.g., reaction time at interactive events; Kelemen and Fenton,
2010). This coordination of information to select appropriate
behavioral responses is believed to be aﬀected by aging (Korsch
et al., 2014).
The order of participating in either the DOT or NAV tasks was
random, and both started after each participant had 5 min to read
written instructions detailing the task, virtual building layout, and
task rules. Then, participants practiced the virtual environment
using gestures to move around the building and completed 3
practice runs involving object collection, button pressing, unlock-
ing the stairwell door with a key code, and folder sorting. This also
allowed participants to familiarize themselves with the building.
None of the practice runs were used in themain task. The practice
session took in total approximately 20 min.
Participants played all diﬃculty levels of DOT and NAV in
a baseline session (Visit 1), again all levels at a 1-month post-
baseline session (Visit 2), and ﬁnally all levels at a 3-month
post-baseline session (Visit 3). A total of three sessions were
measured in order to assess test–retest reliability.
Computation of IIV of DOT and NAV
Performance
In order to apply IIV computations to the DOT and NAV per-
formance proﬁle data, we ﬁrst had to categorize the performance
proﬁles into accuracy-based and latency-based data. Since NAV
was a more complex task than DOT, we conducted a prin-
cipal component analysis (PCA) of participants’ performance
data on the cognitive variables at their initial visit in order to
create composite IIV measures. We then used the Spearman’s
correlations to identify three accuracy- based and three latency-
based performance categories, explained bellow, which place
medium to high demands on higher order cognitive abili-
ties for both DOT and NAV. Across-domain IIV was cal-
culated with tasks representing diﬀerent cognitive domains,
while within-domain IIV was calculated with tasks represent-
ing cognitive control. Additionally, in order to avoid ceiling
or ﬂoor eﬀects, we added performances from each diﬃculty
level and calculated a total performance proﬁle from all diﬃ-
culty levels per cognitive domain and category above in order
to prevent suppressing variation at the extreme ends of the
distribution.
To calculate DOT across-domain accuracy-based IIV, we used
accuracy scores from three data categories, each representing a
diﬀerent cognitive domain: (1) spatial memory accuracy mea-
sured as the correct route selection, such as the nearest emergency
exit or route for the evacuation of the virtual apartment building,
according to the memorized virtual building layout; (2) planning
accuracy measured as the correct order of subroutines execu-
tion, such as ﬁrst sounding the ﬁre alarm and then calling the
ﬁre department; and (3) executive functions accuracy measured
as successful subroutines completion, such as sounding the ﬁre
alarm.
NAV across-domain accuracy-based IIV was calculated using
accuracy scores from three data categories, each representing a
diﬀerent cognitive domain: (1) spatial memory accuracy mea-
sured as correct route selection, such as the nearest route for
navigating from start to goal, according to the memorized virtual
building layout; (2) planning accuracy measured as the correct
order of subroutines execution, such as ﬁrst going to point B and
then to point C before goal; and (3) executive functions accuracy
measured as successful subroutines completion, such as reaching
each point from start to goal.
For calculating DOT within-domain accuracy-based IIV, we
used accuracy performance data from three categories, each
representing executive functions and eliciting recruitment of
cognitive control processes. We calculated: (1) omissions of
the subroutines, (2) repetition of the same subroutine, and (3)
perseverations of incorrect order while performing the sub-
routines before completing the given script per diﬃculty level.
According to the literature, virtual reality-based navigation, and
interactions, such as the DOT task process, require participants
to generate, maintain, and monitor a plan and to select and
establish speciﬁc responses—therefore, accessing cognitive con-
trol (Cushman et al., 2008).
Accordingly, for calculating NAV within-domain accuracy-
based IIV, we used accuracy performance data from: (1) omis-
sions of the destination points between start and goal, (2) rep-
etition of the same destination point, and (3) perseverations of
incorrect order while navigating to the goal before completing the
given script per diﬃculty level. Participants needed to maintain a
goal while inhibiting a routine response in favor of a less familiar
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one, a process which typically involves cognitive control (West
et al., 2002).
The DOT across-domain latency-based IIV was calculated
using performance data from the participant’s timed response
within three data categories, each representing a diﬀerent cog-
nitive domain: (1) total time to complete the navigation route per
diﬃculty level, according to the memorized virtual building lay-
out; (2) total time to complete the order of emergency evacuation
subroutines execution; and (3) time of execution through accel-
eration data, such as “fast hand pointing gestures,” per subroutine
completion.
In order to calculate the NAV across-domain latency-based
IIV, we used performance data from the participant’s timed
response at: (1) total time to complete the navigation route
per diﬃculty level; (2) gait frequency at interactive events,
such as avoidance of moving obstacles and distractors; and (3)
gait parameters such as stride length, distance, and variabil-
ity of stride while completing the navigation per destination
point.
DOT within-domain latency-based IIV was calculated using
timed response performance data from the following categories,
eliciting recruitment of cognitive control processes: (1) reaction
time of “navigation gestures” usage, measured as the time elapsed
between the virtual character idle state and the next immediate
“direction command”; (2) reaction time of “interaction gestures”
usage, measured as the time elapsed between the virtual char-
acter idle state and the next immediate interaction response to
the virtual environment, such as “open door action”; and (3)
reaction time at interactive events, such as avoidance of moving
obstacles.
Finally, to calculate NAVwithin-domain latency-based IIV, we
used timed response performance data from the following cate-
gories, eliciting recruitment of cognitive control processes during
DTW: (1) gait velocity during the navigation, measured as the
time elapsed between the virtual character idle state and the next
immediate “direction command”; (2) cadence, measured as steps
per minute between the virtual character idle state and the next
immediate interaction response to the virtual environment, such
as “open door action”; and (3) time in double support during
interactive events, such as avoidance of distractors and moving
obstacles.
Following the work described in recent studies (Nesselroade
and Salthouse, 2004; Kälin et al., 2014), we calculated the intra-
individual standard deviation (ISD) across each individual’s per-
formance proﬁle data in order to compute IIV. Starting from
the accuracy-based IIV and the HCS group, we log-transformed
performance data in order to achieve normal distribution and
multiplied by -1 to adjust for scaling diﬀerence. This process
generated for HCS standardized residuals representing adjusted
accuracy and latency scores with a mean of 0 and variance of
∼ 1. We used the General Linear Model to estimate eﬀects asso-
ciated with age, education, gender, and potential interactions.
The model parameters were used to predict accuracy scores in
aMCI and early AD subjects. We then calculated standardized
residuals for aMCI and early AD subtracting the predicted from
the observed accuracy scores and dividing it by the model’s
SE. Similar to the work of Kälin et al. (2014), we used the
intra-individual mean (IIM) across residuals underlying across-
domain IIV (across-domain IIM) and across residuals underlying
within-domain IIV (within-domain IIM) as covariates in all rele-
vant analyses in order to address the association between ISD and
mean performance.
Accordingly, for the latency-based IIVwe followed data prepa-
ration procedures similar to those of Bielak et al. (2010). We
removed the high and low outliers in reaction time from each per-
formance proﬁle category for each participant. We deﬁned high
outliers as the individual reaction times that were greater than
3 SD more than the person’s mean reaction time and low out-
liers as individual reaction times less than 3 s. After the outliers
were removed, we recalculated mean RT and within-person ISDs
for each participant. In order to remove the eﬀect of mean RT
from the ISDs, since mean RT is positively associated with vari-
ability, and age is associated with slower reaction times (Anstey
et al., 2007), we regressed the ISDs on mean RT and collected
standardized ISD residuals. Finally, the ISDs of all variables were
normally distributed, and we calculated the across-domain IIV
and within-domain IIV composite scores of the standardized
residuals.
Genotyping Data
Weused restriction isotyping to classify participants as either car-
riers (APOE ε2/ε4, ε3/ε4, and ε4/ε4) or non-carriers of the APOE
ε4 allele. A similar approach is also described in another IIV study
(Kälin et al., 2014).
Statistics
All analyses were performed as two-tailed tests using the sta-
tistical analysis software package PASW 18.0 for Windows. We
used univariate analysis of variance (ANOVA) to perform the
group comparisons of normally distributed demographic, raw,
and adjusted performance data applying Sidak post hoc tests
correcting for multiple comparisons. Not normally distributed
variables were analyzed with Kruskal–Wallis tests followed by
Mann–Whitney tests corrected for multiple comparisons, and
categorical variables were analyzed with Pearson’s chi-square test.
Diﬀerence in across- and within-domain IIV was analyzed with
univariate analyses of covariance (ANCOVA) in order to evalu-
ate group-wise diﬀerences with the diagnostic group treated as
the main eﬀect. The inﬂuences of age, gender, and education as
well as across- and within-domain IIM were also used as covari-
ates to control for inﬂuences on IIV. To calculate the eﬀect of
the IIV type (accuracy- vs. latency-based), we used multivari-
ate analyses of covariance (MANCOVA), and to account for the
unbalanced designed we applied Sum of Square Type III. We
calculated signiﬁcant group eﬀects using a Sidak post hoc test cor-
recting for multiple comparisons. Finally, all parametric analyses
were performed with a signiﬁcance level of p < 0.05, while a
signiﬁcance level of p < 0.017 (0.05/3 = 0.017) was applied for
non-parametric analyses.
Following a recent study (Montero-Odasso et al., 2014), gait
variability was calculated as the coeﬃcient of variation for stride
time: CV = (SD of stride time/mean stride time) × 100. Gait
velocity (cm/s) and stride time variability (CVst, %) were mea-
sured during the NAV dual-task trials.
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We assessed the test–retest reliability with the intraclass corre-
lation coeﬃcient (ICC) as deﬁned by Shrout and Fleiss (1979).
This form of ICC utilizes a two-way ANOVA in which both
the SG performance data and participants are treated as ran-
dom eﬀects to assess reliability at a single point in time. Using
this model, test–retest reliability was characterized as excellent
(ICC N 0.8), good (ICC 0.6–0.79), moderate (ICC 0.4–0.59),
fair (ICC 0.2–0.39), or poor (ICC b 0.2; Kam et al., 2012).
We assessed the stability of ICC using three SG data col-
lection sessions by calculating the ICC values from the ﬁrst
two sessions and comparing them to the values from all three
sessions.
Results
The baseline demographic details are summarized in Table 1,
including IIV computations from the baseline neuropsycholog-
ical performance.
In general we observed a main eﬀect between diagnos-
tic groups and IIV [F(2,225) = 7.87; p = 0.001; η2 = 0.07].
We also observed that IIV in general was inﬂuenced by
age [F(1,225) = 4.21; p = 0.03; η2 = 0.03] and by IIM,
although the eﬀect size was not signiﬁcant [F(1,225) = 3.63;
p = 0.06; η2 = 0.02], but not by education [F(1,225) = 0.12;
p = 0.72; η2 = 0.00] or gender [F(1,225) = 1.78; p = 0.27;
TABLE 1 | Clinical characteristics of the subjects (means with SDs).
Population
N 227
Subgroups HCS aMCI Early AD
n 76 65 86
Age (years) 70.06 (13.32) 72.63 (10.05) 76.59 (10.58)
Female 38 (65%) 40 (62%) 54 (63%)
Education 16.1 (6.4) 15.6 (8.0) 8.6 (5.6)
Neuropsychological data
Global MMSE 29.1 (0.6)∗∗ 27.1 (0.8)∗∗ 22.3 (4.2)∗∗
Memory Free recall† 43.2 (9.1)∗∗ 35.6 (10.9)∗∗ 22.2 (10.8)∗∗
RAVLT delayed recall 12.7 (1.8)∗∗ 11.0 (3.1)∗∗ 9.3 (10.4)∗
Digit span forward 6.0 (2.1)∗∗ 5.0 (2.1)∗∗ 3.0 (1.9)∗∗
Attention Stroop trial 3 47.5 (11.1)∗ 42.1 (13.4)∗∗ 28.6 (15.3)∗∗
TMTB 140.4 (53.3)∗∗ 198.4 (91.9)∗∗ 220.5 (204.2)∗∗
Letter fluency 10.5 (2.9)∗∗ 8.8 (3.4)∗∗ 5.6 (2.8)∗∗
Category fluency 19.3 (2.9)∗ 18.8 (2.2)∗∗ 16.5 (2.8)∗∗
Psychomotor data
Gait speed, m/s Combined 0.95 (0.2) 0.92 (0.2) 0.88 (0.2)
Women 0.94 (0.2) 0.83 (0.0) 0.77 (0.1)
Men 1.02 (0.1) 1.01 (0.0) 0.95 (0.6)
Tapping speed dominant, taps/second Combined 5.88 (0.8) 5.76 (0.8) 5.74 (0.9)
Women 5.53 (0.7) 5.49 (0.8) 5.43 (0.7)
Men 6.29 (0.7) 6.21 (0.7) 6.19 (0.7)
Tapping speed non-dominant, taps/second Combined 5.63 (0.6) 5.61 (0.7) 3.58 (0.7)
Women 5.41 (0.5) 5.38 (0.6) 5.33 (0.6)
Men 5.91 (0.6) 5.96 (0.6) 5.90 (0.6)
Baseline gait performance
Velocity, cm/s Simple gait 112.9 (15.6)∗ 96.5 (25.1)∗ 89.5 (30.4)∗
Counting gait 107.1 (20.7)∗ 89.3 (22.4)∗∗ 70.3 (25.5)∗∗
Naming animals gait 98.3 (23.3)∗ 78.6 (23.3)∗∗ 69.1 (21.3)∗∗
Stride time variability (CV, %) Simple gait 2.34 (1.3)∗ 3.53 (2.3)∗ 4.11 (2.6)∗
Counting gait 2.80 (0.6)∗∗ 4.90 (3.4)∗∗ 6.81 (3.3)∗∗
Naming animals gait 3.99 (2.1)∗∗ 5.73 (6.0)∗∗ 7.65 (5.0)∗∗
Neuropsychological data IIV
Across-domain IIM 0.00 (0.6)∗∗ −1.41 (0.9)∗∗ −2.34 (0.8)∗∗
Within-domain IIM 0.01 (0.9)∗∗ −0.53 (0.9)∗∗ −1.80 (1.0)∗∗
Across-domain IIV‡ 0.92 (0.6)∗ 0.96 (0.6)∗ 1.37 (0.8)∗∗
Within-domain IIV‡ 0.81 (0.6)∗∗ 1.12 (0.6)∗ 1.25 (0.7)∗∗
† Free recall: sum of the three free recalls.
‡Analyses of covariance, means adjusted for gender, age, and education and across- or within-domain IIM.
∗p < 0.05, ∗∗p < 0.001.
HCS, healthy control subjects; MCI, mild cognitive impairment; AD, Alzheimer’s disease; MMSE, mini-mental state examination; TMT, trail making test; IIM, intra-individual
mean; IIV, intra-individual variability.
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η2 = 0.007]. Groups did not diﬀer in years of education
(F(2,225) = 1.30, p= 0.33) or distribution of gender [χ2(2) = 0.29,
p = 0.89]. HCS and aMCI did not diﬀer in age [t(225) = −1.36,
p = 0.36].
Accuracy-Based Comparisons Between
Across-Domain and Within-Domain IIV
The accuracy-based IIV at both DOT and NAV was not inﬂu-
enced by education [F(1,225) = 2.41; p = 0.13; η2 = 0.01),
gender [F(1,225) = 2.12; p = 0.10; η2 = 0.01], or IIM
[F(1,225) = 1.20; p = 0.19; η2 = 0.01] but diﬀered among
diagnostic groups [F(2,225) = 5.75; p = 0.001; η2 = 0.06] and
slightly by age [F(1,225) = 1.06; p = 0.05; η2 = 0.02]. The
early AD group revealed in general higher across-domain IIV
than both the aMCI group (p = 0.001; 95% CI = 0.17–0.88)
and HCS group (p = 0.001; 95% CI = 0.18–0.99), whereas
IIV did not diﬀer signiﬁcantly between the aMCI and HCS
groups (p = 0.71; 95% CI = –0.16–0.31). Within-domain
IIV was not inﬂuenced by age [F(1,225) = 0.056; p = 0.82;
η2 = 0.00] but was higher in the early AD group com-
pared to the HCS group (p = 0.006; 95% CI = 0.12–
0.85) and was not signiﬁcant between the early AD and
the aMCI groups (p = 0.374; 95% CI = 0.142–0.582).
In addition, we found a strong trend for higher within-
domain IIV in the aMCI group than in the HCS group
(p = 0.051; 95% CI = –0.02–0.27). To avoid statistical issues
associated with two missing trials for the DOT group, group-
level ISD values were imputed for missing data (<3% of
the total data). Figure 2 summarizes the accuracy-based IIV
results.
Latency-Based Comparisons between
Across-Domain and Within-Domain IIV
The latency-based IIV at both DOT and NAV was also not inﬂu-
enced by education [F(1,225) = 2.43; p = 0.15; η2 = 0.01], gender
[F(1,225) = 2.21; p = 0.13; η2 = 0.01], or IIM [F(1,225) = 1.19;
p = 0.20; η2 = 0.01] but diﬀered among diagnostic groups
[F(2,225) = 5.71; p = 0.001; η2 = 0.06] and age [F(1,225) = 1.51;
p = 0.02; η2 = 0.03]. The across-domain latency-based IIV dif-
fered between the early AD and aMCI groups (p = 0.001; 95%
CI = 0.22–1.07) as well as between the AD and HCS groups
(p = 0.001; 95% CI = 0.24–1.29) and also between the aMCI and
HCS groups (p = 0.001; 95% CI = 0.26–1.30). Within-domain
latency IIV was found to be higher in the early AD group com-
pared to the aMCI group (p= 0.001; 95%CI= 0.19–0.85) and the
HCS group (p= 0.001; 95% CI= 0.16–0.82) and also between the
aMCI andHCS groups (p= 0.001; 95% CI= 0.20–0.97). Figure 3
summarizes the accuracy-based IIV results.
Accuracy-Based IIV vs. Latency-Based IIV
In order to evaluate whether there was a relationship between
the accuracy- and latency-based IIV scores and the SG task, a
MANCOVA was performed with IIV type (accuracy- or latency-
based) and task (DOT and NAV) included as covariates. There
was a signiﬁcant main eﬀect of the IIV type for the group
[F(2,225) = 29.9; p = 0.001; η2 = 0.41], but not for task, age,
education, or gender.
In addition, ANCOVA was performed in order to calculate
a diﬀerence score by subtracting within- from across-domain
IIV while treating age, education, and gender as covariates.
For the accuracy-based IIV, we found only a tendency toward
FIGURE 2 | Comparison of accuracy-based intra-individual variability
(IIV) scores between diagnostic groups: intra-individual standard
deviation (ISD) representing mean across-domain IIV for DOT and NAV
as well as mean within-domain IIV for DOT and NAV per diagnostic
group (HCS, healthy control subjects; MCI, mild cognitive impairment;
AD, Alzheimer’s disease). Error bars display 95% confidence interval for the
mean with p values based on Sidak post hoc tests following analyses of
covariance for the comparison of means adjusted for age, years of education
and gender as well as mean across-domain performance (A) and mean
within-domain performance (B), respectively.
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FIGURE 3 | Comparison of latency-based IIV scores between diagnostic groups.
higher across-domain IIV—not within-domain IIV—in each
group (HCS: M = 0.21, SD = 0.76; MCI: M = 0.08, SD = 0.81;
AD: M = 0.38, SD = 0.95). On the other hand, the latency-based
IIV revealed no signiﬁcant diﬀerences between IIV scores across
diagnostic groups [F(2,225) = 4.32; p = 0.16; η2 = 0.15].
Associations between IIV, Genotype, and
Neuropsychological Tests
Correlations are given in Table 2. The relationship between IIV,
neuropsychological tests, and APOE status was explored in a sub-
sample with available genotypes. We performed ANCOVAs to
compare IIV scores between ε4 carriers and non-carriers within
each group by treating gender as a covariate in aMCI. We cal-
culated the general across-domain IIV and found that it did
not vary with APOE status in HCS [F(1,75) = 0.412; p = 0.37;
η2 = 0.003], MCI [F(1,51) = 0.316; p = 0.54; η2 = 0.008], or
AD [F(1,33) = 0.012; p = 0.87; η2 = 0.00]. Similarly, the within-
domain IIV did not vary as a function of APOE status in early
AD [F(1,33) = 0.219; p = 0.67; η2 = 0.01], but there was a sig-
niﬁcant eﬀect of APOE status in HCS [F(1,75) = 4.393; p = 0.04;
η2 = 0.04] and aMCI [F(1,51) = 2.399; p= 0.05; η2 = 0.03], which
indicated increased within-domain IIV in these groups.
Reliability of Performance-Based IIV Data
Figure 4 for the DOT task and Figure 5 for the NAV task summa-
rize the reliability data. ICC values were calculated using all three
SG sessions for both the accuracy- and latency-based IIV of the
DOT and NAV tasks. Results showed that, in general, accuracy-
based IIV elicits fair to moderate reliability (ICC 0.33–0.57)
for both the DOT and NAV tasks. In addition, accuracy-based
ICC values increased after all three SG sessions for the DOT
task, but the NAV task elicited an average ICC decrease of 0.15
(SEM = 0.04). In contrast, latency-based IIV for both the DOT
and NAV tasks exhibited good to excellent reliability measures
(ICC 0.69–0.85) after all sessions.
Discussion
A major problem in studying aging is how to separate the eﬀects
of aging from disease, and the two most pressing clinical ques-
tions relate to etiology and prognosis. In this study, we examined
SG with and without DTWperformance data and applied across-
and within-domain accuracy-based and latency-based IIV mea-
sures in order to reliably diﬀerentiate between HCS, aMCI, and
early AD. Speciﬁcally for the SG with DTW, we found increased
IIV for both across- and within-domain IIV in early AD vs. HCS,
aMCI vs. HSC, and in early AD vs. aMCI, consistent with a recent
study (Phillips et al., 2013). In addition, and consistent with the
literature on within-domain IIV (Duchek et al., 2009; Schroeter
et al., 2012) placing more demands on cognitive control pro-
cesses, we also found SGwith DTW latency-based within-domain
IIV being increased in early AD vs. HCS, aMCI vs. HCS, and early
AD vs. aMCI, which is found to be a sensitive early marker of
cognitive impairment (MacDonald et al., 2012; Kälin et al., 2014).
High IIV has been linked to an increased probability that an indi-
vidual with aMCI will become demented within 2.5 years (Tales
et al., 2012).
When one investigates SG-based human navigation—in par-
ticular, the strategies implemented in a complex everyday
way-ﬁnding task—one must also consider the role of vision in
walking. In order to maintain a regular walking velocity in the
SG, subjects must anticipate visualizing the destination route and
process the responses upstream without having to stop. During
the NAV task, each way-point had several action points as well
as distractors and required several hesitant jerky movements to
process them. Using the IIV measures, we were able to verify
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TABLE 2 | Cognitive measures per diagnostic group, IIV, and APOE genotype (means with SDs).
Population
N 161
Subgroups HCS aMCI Early AD
n 16 60 34 18 21 12
APOE status ε4+ ε4− ε4+ ε4− ε4+ ε4−
Age (years) 72.6 (12.02) 70.1 (13.21) 74.1 (9.21) 72.7 (9.44) 76.5 (8.83) 77.8 (9.36)
Male 7 (43.7%) 22 (36.6%) 12 (35%) 7 (38.8%) 8 (38%) 6 (50%)
Female 9 (56.3%) 38 (63.4%) 22 (65%) 11 (61.2%) 13 (62%) 6 (50%)
Education 15.1 (5.9) 15.3 (6.0) 14.5 (7.1) 15.1 (7.4) 8.7 (6.0) 9.1 (5.2)
Neuropsychological data
Global MMSE 29.3 (1.0) 28.9 (0.8) 26.8 (1.9) 27.3 (1.7) 22.1 (3.5) 22.7 (3.2)
Memory Free recall† 0.02 (1.1) −0.01 (1.1) −0.59 (0.6) −0.62 (0.7) −0.49 (1.3) −0.45 (1.0)
RAVLT delayed recall† −0.08 (1.0) 0.06 (0.9) −2.23 (1.6) −2.14 (1.5) −3.88 (1.6) −3.79 (1.4)
Digit span forward† 0.35 (1.0) −0.09 (1.0) −1.43 (1.0) −0.99 (1.1) −2.35 (1.5) −2.59 (1.1)
Attention Stroop trial 3† 0.03 (0.9) 0.08 (1.1) −0.69 (0.9) −0.37 (1.1) −2.83 (2.4) −2.99 (2.0)
TMTB† 0.61 (1.2)∗ −0.08 (1.2)∗ 0.75 (1.3)∗ −0.22 (1.3)∗ −1.27 (1.6) −0.36 (1.5)
Letter fluency† 0.59 (0.9)∗ −0.11 (1.1)∗ 0.67 (1.1)∗ −0.25 (1.4)∗ −1.32 (1.5) −0.24 (1.3)
Category fluency† 0.57 (1.0)∗ −0.09 (1.0)∗ 0.69 (1.2)∗ −0.19 (1.3)∗ −1.39 (1.3) −0.49 (1.3)
IIV
Across-domain IIM 0.09 (0.6) 0.01 (0.6) −1.39 (0.7) −1.24 (0.6) −2.38 (1.2) −2.67 (0.9)
Within-domain IIM 0.33 (0.7) −0.10 (0.8) −0.49 (0.5) −0.56 (0.9) −1.91 (1.1) −1.56 (1.0)
Across-domain IIV‡ 0.81 (0.5) 0.77 (0.6) 1.09 (0.7) 1.23 (0.2) 1.79 (0.6) 1.86 (0.8)
Within-domain IIV‡ 0.56 (0.5)∗ −0.18 (0.5)∗ 0.57 (0.4)∗ −0.22 (0.5)∗ 1.35 (0.8) 1.48 (1.1)
† Data shown are calculated standardized residuals of cognitive test scores for MCI and AD by using parameter estimates for age, education, and gender in HCS.
‡Analyses of covariance, means adjusted for gender, age, education, and across- or within-domain IIM.
∗p < 0.05.
HCSs, healthy control subjects; MCI, mild cognitive impairment; AD, Alzheimer’s disease; MMSE, mini–mental state examination; TMT, trail making test; IIM, intra-individual
mean; IIV, intra-individual variability.
FIGURE 4 | Behavioral results for the DOT task. ICC values from (A) accuracy-based and (B) latency-based IIV times with 3 and 2 experimental sessions. Error
bars represent 95% confidence interval.
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FIGURE 5 | Behavioral results for the NAV task. ICC values from (A) accuracy-based and (B) latency-based IIV times with 3 and 2 experimental sessions. Error
bars represent 95% confidence interval.
that NAV task interference is preserved in dual-task conditions,
consistent with other recent studies, i.e., (Perrochon et al., 2013).
The role of vision in gait control during locomotion has
been demonstrated by other studies, especially when the envi-
ronment is enriched with visual information (Chapman and
Hollands, 2006, 2007). During NAV, this mechanism triggered
a modiﬁcation in gait parameters, such as a reduction in veloc-
ity and frequency, and more so by an increase in double support
time. At the same time, others have suggested that elders with
reduced cognitive ability have more diﬃculty identifying the
environment, and it is necessary to ﬁxate more to have a max-
imum of visual information (Di Fabio et al., 2005). In another
study, Scherder et al. (2011) demonstrated that one can predict
a change in walking control and motor performance in sub-
groups of patients with dementia pathology using the concept of
“last in-ﬁrst out,” —that is, the neuronal circuits that mature late
would be the ﬁrst to deteriorate in neurodegenerative pathology.
In that study, subjects with frontotemporal or vascular demen-
tia had diﬃculties at the motor level in coordinating complex
foot movements and planning movements associated with early
degeneration of the anterior cingulate cortex and dorsolateral
prefrontal cortex. In another study, Gwin et al. (2011) performed
an electroencephalogram on a subject walking on DTW and
noted activation of the anterior cingulate cortex during place-
ment of the foot, similar to the detection of an error in placing
the foot on the ﬂoor and correction of its trajectory. During the
NAV task, one could imagine that there is a conﬂict at the level
of the anterior cingulate cortex, which simultaneously manages
performance of the cognitive task and correct placement of the
foot. This conﬂict at the level of the anterior cingulate cortex
could be increased in early AD because this cerebral zone is often
prematurely deteriorated in patients with dementia.
We also examined the stability of measurements. Our results
found at both the SG accuracy- and latency-based measures
an increased IIV, suggesting a breakdown of cognitive control
functions early in prodromal AD. More precisely, across- and
within-domain accuracy-based IIV diﬀered between each group,
underlying the diﬀerences in cognitive control required by the
DOT and NAV tasks. Consistent with other studies (Kälin et al.,
2014), we also found that accuracy-based within-domain IIV was
increased in early AD and aMCI vs. HCS and appeared to con-
stitute a reliable marker for the detection of prodromal AD at the
MCI stage.We also found that accuracy-based across-domain IIV
was increased in early AD vs. aMCI and HCS and may be used to
separate early AD from the aMCI stage.
Furthermore, since higher IIV has been found in tasks requir-
ing cognitive control to be inﬂuenced by gender, by task-related
processing load and processing speed (MacDonald et al., 2009;
Phillips et al., 2013; Koﬂer et al., 2014), previous studies found
that MCI subjects who later converted to dementia were found to
have higher IIV than non-converters. Consistent with this study
and the literature on latency-based within-domain IIV (Duchek
et al., 2009; Schroeter et al., 2012) placing more demands on
cognitive control processes, we also found latency-based within-
domain IIV being increased in early AD vs. HCS, aMCI vs. HCS,
and early AD vs. aMCI.
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Additionally, we found increased within-domain IIV in HCS
and aMCI ε4 carriers vs. non-carriers, whereas there was no ε4-
related change in IIV in the early AD group. Contrary to ﬁndings
reported by others (Duchek et al., 2009; Kälin et al., 2014) who
only found an increased latency-based IIV in a cognitive control
task in HCS ε4 carriers vs. non-carriers, we also found increased
latency-based IIV in aMCI ε4 carriers vs. non-carriers. One rea-
son for our ﬁndings might be that, in contrast to the previous
studies, we examined the relationship between accuracy- and
latency-based intra-individual diﬀerences in trial-to-trial vari-
ability. Another reason might be that the SG performance data
are sensitive enough to detect subtle changes in IIV at both the
HCS and aMCI stages. However, such interpretations should be
treated with caution as it is already known that the frontal lobe
constitutes a brain region that manifests ε4-eﬀects very early in
the disease (Filbey et al., 2010). Since the frontal lobe is believed
to be the basis of IIV (MacDonald et al., 2009), our ﬁndings add
evidence to recent studies (Kälin et al., 2014) and further support
the relationship between within-domain IIV and APOE status.
In order to assess the reliability of performance data IIV, we
analyzed the stability of test–retest measurements for both the
DOT and NAV tasks using ICC values. Given that longitudi-
nal change in IIV among accuracy and response time is thought
to be particularly important and robust in signaling the risk of
cognitive impairment and dementia (Vaughan et al., 2013), this
result underscores the importance of utilizing response time data
as a metric for memory processes, especially in aMCI popula-
tions where memory decline is often the behavioral outcome of
interest.
In summary, our results demonstrated that SG with DTW
performance proﬁles data represents another aspect of cognition
that underlies age-related diﬀerences in cognitively demanding
tasks independently of mean reaction time and executive func-
tion. Importantly, our ﬁndings conﬁrmed that impaired cognitive
control processes, especially in terms of latency, as measured with
NAV performance proﬁles, produce stable inconsistencies across
IIV in cognitive control-sensitive tasks, and hence can act as a
predictor of greater cognitive decline.
Consistent with other studies, we found intra-individual dif-
ferences in cognitive domains, both cross-sectional as well as
longitudinal, which can be used for early detection and inter-
vention. Recently, evidence for a strong association between IIV
and frontal gray and white matter integrity changes onMRI scans
(volumetric decline, demyelination, and hyperintensities) due to
age-related changes in cerebral bold ﬂow, vascular injury, or neu-
rological conditions such as AD (Jackson et al., 2012; Lövdén
et al., 2013; Radanovic et al., 2013) support the idea of frontal sys-
tem disruptions underlying increased IIV in aMCI and early AD.
Our study has strengths but also limitations. One limita-
tion was the small variability of the education proﬁles of our
groups, which were all considered to be highly educated older
adults. Although recent studies (Kälin et al., 2014) found no
eﬀect between education and IIV, this risk was addressed by
treating education and within- and across-domain IIM as covari-
ates in all analyses. Furthermore, the outcome of interest in
the present study was the ISD calculated across tasks, and thus
we assume the risk to be minimal. Another limitation was the
correlation of SG performance proﬁle data with neuropsycho-
logical tasks that might not exclusively assess the same cognitive
functions. Speciﬁcally, the NAV task requiredmotor performance
with complex cognitive abilities, such as processing speed, visuo-
construction, and inhibition, among other cognitive control
functions. Neuropsychological tasks, such as the TMT, the Letter
and Category Fluency task, the Stroop Test, and the RAVLT place
fewer demands on cognitive control processes, which might have
inﬂuenced the signiﬁcance of our correlations. Finally, the motor
performance seen in subjects with aMCI is likely to be linked to
early degeneration of the dorsolateral prefrontal cortices as well as
the anterior cingulate cortex, and these subjects would be suscep-
tible to progressive dementia pathology, such as frontotemporal
and vascular dementia and not only AD. Brain imaging will be
used in a future study to conﬁrm or refute this hypothesis.
Despite these limitations, SGwith DTWmight useful in every-
day clinical practice. Compared to other non-invasive biomarkers
such asMRI, using SG performance data in clinical practice could
optimize the diagnosis of AD at the early stage of the disease and
would provide the greatest beneﬁt in terms of cost and risk com-
pared with other techniques. Finally, we suspect that integrating
this type of dual-tasking with training programs or physical ther-
apy, in an acute training design, might delay cognitive and motor
decline in the elderly. However, further examination using diﬀer-
ent custom SG tasks in a longitudinal design is needed to provide
more speciﬁc information about their preventive value.
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